Farms.com Home   Ag Industry News

Breeding lentils for higher yields with less resources

Breeding lentils for higher yields with less resources

U of S maps two of the largest legume genomes ever

By Kate Ayers

Staff Reporter

Farms.com

University of Saskatchewan (U of S) researchers and genomic company NRGene of Israel have sequenced two lentil genomes.

The two wild legume genomes that were mapped are the largest legume genomes ever assembled, according to Wednesday’s university release.

The project is looking to diversify the genetics of lentils grown in Canada.

“One of the (project’s) goals is to really understand the difference between the domesticated lentils that are grown in Canada versus wild lentils plants … to see if we can bring in beneficial traits from the wild species into our (lentil varieties),” Crystal Chan, project co-ordinator of the department of plant sciences at U of S said to Farms.com on Friday.

NRGene has made significant contributions to this project and the research is expected to propel lentil breeding efforts forward.

“NRGene’s technology has dramatically accelerated our research, which aims to shed light on lentil domestication and adaptation,” Kirstin Bett, a project lead at U of S, said in the release.

“Maintaining sustainable lentil production will play an important role in addressing the world’s need for an ecologically sound protein source that is also highly nutritious.”

The NRGene technology is crucial in making this research happen due to the vastness and complexity of the lentil genome.

“Without (NRGene, genome assembly) would take us probably another year and the quality wouldn’t be as good as (NRGene) has provided us,” said Chan.

Previously, breeders were only able to access a small fraction of germplasm diversity.

The research is expected to have an immediate impact on the world food supply, according to the release.

Canada is the world’s largest exporter of lentils, providing the crop for India, Pakistan, and Bangladesh. Lentils are a principle protein source in these countries.

“By being able to maintain the productivity through expanding the diversity in the breeding program, we will be able to continue to be the leading exporter,” said Chan.

Genome Canada is funding the $7.9-million research project, which is led by scientists Bett and Bert Vandenberg.

 

Photo credit: Derek Wright for the University of Saskatchewan  


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.